BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15831460)

  • 21. The VP16 activation domain establishes an active mediator lacking CDK8 in vivo.
    Uhlmann T; Boeing S; Lehmbacher M; Meisterernst M
    J Biol Chem; 2007 Jan; 282(4):2163-73. PubMed ID: 17135252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A class of activation domains interacts directly with TFIIA and stimulates TFIIA-TFIID-promoter complex assembly.
    Kobayashi N; Boyer TG; Berk AJ
    Mol Cell Biol; 1995 Nov; 15(11):6465-73. PubMed ID: 7565798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CBP Regulates Recruitment and Release of Promoter-Proximal RNA Polymerase II.
    Boija A; Mahat DB; Zare A; Holmqvist PH; Philip P; Meyers DJ; Cole PA; Lis JT; Stenberg P; Mannervik M
    Mol Cell; 2017 Nov; 68(3):491-503.e5. PubMed ID: 29056321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcription factors GAF and HSF act at distinct regulatory steps to modulate stress-induced gene activation.
    Duarte FM; Fuda NJ; Mahat DB; Core LJ; Guertin MJ; Lis JT
    Genes Dev; 2016 Aug; 30(15):1731-46. PubMed ID: 27492368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mediator, not holoenzyme, is directly recruited to the heat shock promoter by HSF upon heat shock.
    Park JM; Werner J; Kim JM; Lis JT; Kim YJ
    Mol Cell; 2001 Jul; 8(1):9-19. PubMed ID: 11511356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoter structure and transcriptional activation with chromatin templates assembled in vitro. A single Gal4-VP16 dimer binds to chromatin or to DNA with comparable affinity.
    Pazin MJ; Hermann JW; Kadonaga JT
    J Biol Chem; 1998 Dec; 273(51):34653-60. PubMed ID: 9852139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of histone H3 at Ser10 facilitates RNA polymerase II release from promoter-proximal pausing in Drosophila.
    Ivaldi MS; Karam CS; Corces VG
    Genes Dev; 2007 Nov; 21(21):2818-31. PubMed ID: 17942706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide Single-Molecule Footprinting Reveals High RNA Polymerase II Turnover at Paused Promoters.
    Krebs AR; Imanci D; Hoerner L; Gaidatzis D; Burger L; Schübeler D
    Mol Cell; 2017 Aug; 67(3):411-422.e4. PubMed ID: 28735898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weak transcriptional activation is sufficient for transformation by v-Myb.
    Engelke U; Whittaker L; Lipsick JS
    Virology; 1995 Apr; 208(2):467-77. PubMed ID: 7747419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different upstream transcriptional activators have distinct coactivator requirements.
    Lee DK; Kim S; Lis JT
    Genes Dev; 1999 Nov; 13(22):2934-9. PubMed ID: 10580000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of promoter Pol II on Hsp70 reveal stable pausing and key insights into its regulation.
    Buckley MS; Kwak H; Zipfel WR; Lis JT
    Genes Dev; 2014 Jan; 28(1):14-9. PubMed ID: 24395245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fcp1 dephosphorylation of the RNA polymerase II C-terminal domain is required for efficient transcription of heat shock genes.
    Fuda NJ; Buckley MS; Wei W; Core LJ; Waters CT; Reinberg D; Lis JT
    Mol Cell Biol; 2012 Sep; 32(17):3428-37. PubMed ID: 22733996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeras of herpes simplex viral VP16 and jun are oncogenic.
    Schuur ER; Parker EJ; Vogt PK
    Cell Growth Differ; 1993 Sep; 4(9):761-8. PubMed ID: 8241024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides.
    Wu TJ; Monokian G; Mark DF; Wobbe CR
    Mol Cell Biol; 1994 May; 14(5):3484-93. PubMed ID: 8164693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic mammalian trigger-controlled bipartite transcription factors.
    Folcher M; Xie M; Spinnler A; Fussenegger M
    Nucleic Acids Res; 2013 Jul; 41(13):e134. PubMed ID: 23685433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spt6 enhances the elongation rate of RNA polymerase II in vivo.
    Ardehali MB; Yao J; Adelman K; Fuda NJ; Petesch SJ; Webb WW; Lis JT
    EMBO J; 2009 Apr; 28(8):1067-77. PubMed ID: 19279664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recruitment of TBP or TFIIB to a promoter proximal position leads to stimulation of RNA polymerase II transcription without activator proteins both in vivo and in vitro.
    Huh JR; Park JM; Kim M; Carlson BA; Hatfield DL; Lee BJ
    Biochem Biophys Res Commun; 1999 Mar; 256(1):45-51. PubMed ID: 10066420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of functional interaction between GAGA-containing sites from promoter regions of heat shock genes hsp26 and hsp70 in the model system of Drosophila melanogaster white gene.
    Melnikova LS; Proskuryakov KA; Georgiev PG
    Dokl Biochem Biophys; 2010; 434():266-9. PubMed ID: 20960253
    [No Abstract]   [Full Text] [Related]  

  • 39. Accurate prediction of inducible transcription factor binding intensities in vivo.
    Guertin MJ; Martins AL; Siepel A; Lis JT
    PLoS Genet; 2012; 8(3):e1002610. PubMed ID: 22479205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic competition between elongation rate and binding of NELF controls promoter-proximal pausing.
    Li J; Liu Y; Rhee HS; Ghosh SK; Bai L; Pugh BF; Gilmour DS
    Mol Cell; 2013 Jun; 50(5):711-22. PubMed ID: 23746353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.